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In order to study the presence of antibodies directed against Candida albicans 0-linked oligomannosides
(oligomannosides 0) in patient sera, we have developed an enzyme-linked immunosorbent assay (ELISA)
involving neoglycolipids constructed with these residues (NGLO). Oligomannosides 0 released by mild alkaline
degradation of the C. albicans cell wall phosphopeptidomannan (PPM) contained one to seven mannose
residues, among which the quantitatively major components, mannobiose and mannotriose, were shown by 'H
nuclear magnetic resonance to contain exclusively a (1-2) linkages. The pool of oligomannosides was converted
to neoglycolipids by coupling them to 4-hexadecylaniline in an equimolar reaction checked by thin-layer
chromatography. We have tested against these neoantigens, coated on ELISA plates, 15 pairs of sera
corresponding to individual seroconversions observed in 15 patients during the course of a mycological and
serological survey of candidiasis. For all patients, seroconversions resulted in an increased level of antibodies
against NGLO. A significant correlation was observed between the results of ELISA-NGLO, ELISA involving
the original PPM molecule, and routine antibody detection tests, indirect immunofluorescence assay, and
cocounterimmunoelectrophoresis. These results therefore demonstrate the synthesis of human antibodies
reactive with oligomannosides 0 constitutive of the C. albicans mannan molecule which have been previously
described as exhibiting an inhibitory effect on human lymphocytic proliferation.
Candida albicans mannan polysaccharide is a major com-
ponent of the cell wall whose importance in the physiopa-
thology of candidiasis has been the subject of extensive
studies. It has been shown that mannans determine the
antigenic specificity of Candida species and C. albicans
serotypes as analyzed with polyclonal-adsorbed antibodies
(11, 29). Antimannan antibodies are present in the sera of
most healthy individuals (2) and show an increase during
development of invasive candidiasis in immunocompetent
patients (15). Furthermore, antimannan polyclonal (1) or
monoclonal (10, 19) antibodies allow the detection of anti-
genemia in sera from patients with systemic Candida infec-
tion. Finally, bioclinical and experimental evidence indicates
that mannan is a potent immunomodulator (4).
Recent refinements in methods for fractionation and struc-
ture determination have led to the description of a model for
the structure of these cell wall matrix components extracted
by autoclaving and corresponding to phosphopeptidoman-
nan (PPM) (12, 25, 26). The polysaccharide moiety of the
PPM molecule is linked to the peptide via asparagine (N-
glycoside part) and serine or threonine residues (O-glycoside
part). The N-glycoside part is composed of a highly
branched chain of mannopyrannosyl residues linked by
a(1-6) bonds to which are attached oligosaccharide side
chains, where mannopyrannosyl residues are linked through
ot(1-2), a(1-3), P(1-2), P(1-6), and phosphodiester bonds (7, 8,
12, 14). The O-glycoside component appears to consist of
shorter and unbranched chains (18).
* Corresponding author.
Experimental evidence indicates that individual oligoman-
nosides obtained by depolymerization of the PPM molecule
represent epitopes which have been described as the basis of
rabbit polyclonal-antibody specificities (7, 28). These con-
clusions were reached by application of inhibition reactions
in liquid phase (7, 8, 17). These techniques, which are not
well adapted to the multivalent character of immunoglobulin
M (IgM), the predominant isotype against polysaccharides,
require large quantities of purified oligomannosides and are
poorly adapted to extensive screenings. At the moment,
because of the lack of appropriate methodology, recognition
by human antibodies of the C. albicans oligomannoside
repertoire present in the mannan molecule is virtually un-
known. We have recently developed a method to render
oligomannosides antigenic by coupling them to a carrier
molecule able to bind to a conventional substrate for immu-
noanalysis (Sa, 6). The oligomannosides are coupled to a
lipid, 4-hexadecylaniline, according to a method leading to a
mole-to-mole binding whose efficiency can be vizualized and
assessed after thin-layer chromatography. The purpose of
this work was to use this method to determine if the 0-linked
oligomannosides, which have been recently demonstrated as
exhibiting an inhibitory effect on human lymphocytic prolif-
eration induced by Candida and other antigens (18), elicit an
antibody response during invasive candidiasis.
0-linked oligomannosides, released from the PPM mole-
cule by ,B elimination, were analyzed by thin-layer chroma-
tography and 'H nuclear magnetic resonance (NMR) (for the
two major oligomannosides) before being converted to neo-
glycolipids (NGL) containing 0-linked oligomannosides
(NGLO). NGLO were coated on plates for an enzyme-linked
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TABLE 1. Identification of sera from 15 patients tested with
ELISA procedures against PPM and NGLO
Patient Source of Seruma IFA titer Co-CIE
no.
Service Calbicans score
1 Intensive care Hemoculture D-2 200 0
D+5 1,600 7
2 Intensive care Biopsy D-5 50 0
D+7 400 6
3 Surgery Pleural extrava- D-1 100 0
sation
D+24 400 6
4 Surgery Drain D-30 100 0
D-8 800 5
5 Surgery Pancreatic liquid D-37 100 3
D+4 400 5
6 Surgery Hemoculture D-30 50 0
D-1 400 5
7 Intensive care Bronchial liquid D-26 100 0
D+5 400 5
8 Surgery Peritoneal liquid D-1 100 0
D+ 14 800 7
9 Intensive care Peritoneal liquid D-1 200 0
D+6 800 6
10 Surgery Urine D-15 50 0
D+2 400 5
11 Intensive care Urine D-2 200 4
D+6 800 6
12 Urology Urine D-7 200 0
D+6 800 4
13 Intensive care Urine D-34 50 0
D+50 800 6
14 Intensive care Urine D-1 100 0
D+9 1,600 5
15 Urology Urine D-60 200 4
D-3 800 6
a Identification of sera relates to the date of serum sampling in relation to
mycological examination. D, day; + or -, before or after positive culture.
b Defined as follows: 0, absence of precipitin line; 1, faint, nonspecific
precipitin line; 2, one nonspecific precipitin line; 3 to 7, presence of cospecific
precipitin line with increasing intensities.
immunosorbent assay, and their antigenicity was studied by
probing them with human sera. These sera were retrospec-
tively selected from hospital inpatients who had serocon-
verted during the course of a mycological and serological
survey for candidiasis by indirect immunofluorescence assay
(IFA) and cocounterimmunoelectrophoresis (Co-CIE) pro-
cedures (20). The results of ELISA-NGLO appeared to
correlate with the results of ELISA involving the original
PPM molecule and with results from routine serological
tests. Construction of NGL has provided, for the first time,
evidence for the synthesis of antibodies against 0-linked
oligomannosides.
MATERIALS AND METHODS
Strain. A cloned strain of C. albicans serotype A (VW 32)
was used throughout this study. It was selected because of
its high reactivity against sera from patients suffering from
candidiasis (21).
Human sera. Details for these sera are given in Table 1.
Thirty sera originated from 15 patients who were retrospec-
tively selected according to biological and clinical data
collected in the department of Parasitology-Mycology at the
University Hospital of Lille. The following selection criteria
were applied: (i) patients who had had C. albicans isolated at
least once in large quantities from normally sterile sites
(including blood, catheter, drain, peritoneal and pleural
cavities, biopsies, and pancreatic cyst) or from urine sam-
ples; (ii) patients with probable invasive candidiasis, based
on history and presentation (fever resistant to antibiotics,
response to antifungal therapy); (iii) availability of serial
serum samples for the corresponding patients taken near the
date of positive cultures and demonstrating seroconversion
as analyzed by routine serodiagnostic procedures (IFA and
Co-CIE; see below). Two sera were selected for each of the
15 patients: one from before and one from after seroconver-
sion. As a positive control (C), we used the serum from a
patient who had presented with C. albicans septicemia
proved by three successive positive blood cultures and who
exhibited high levels of antibody against C. albicans.
Routine serological tests. (i) IFA. IFA was performed with
C. albicans VW 32 blastoconidia (20). Standardization of
this test was achieved by the use of a pool of sera from
patients with candidiasis (Bio-Merieux, Marcy l'Etoile,
France). A titer equal to or greater than 400 is considered
indicative of candidiasis.
(ii) Co-CIE. Co-CIE with a soluble extract of VW 32
blastoconidia was used to detect precipitating antibodies
presenting a line of identity with an anti-VW 32 germ tube
antiserum (20). This line of identity is named the cospecific
precipitin line (CSPL). Interpretation of Co-CIE results
refers to presence or absence of CSPL and quantitative
evolution of the CSPL (migration towards the cathode which
increases in intensity for successive sera from the same
patients). Quantification of the results obtained by Co-CIE
was needed for statistical analysis, and results were ex-
pressed through scores defined as follows: 0, absence of
precipitin line; 1, faint, nonspecific precipitin line; 2, one
nonspecific precipitating line; 3 to 7, presence of CSPL with
increasing intensities.
Obtainment and analysis of 0-linked oligomannosides. (i)
Production of PPM. PPM was extracted from yeast cells
grown in bioreactors according to the method described by
Kocourek and Ballou (13). The procedure was modified in
that a single extraction in citrate buffer was made (6).
(ui) Mild acid hydrolysis. According to the method of Faille
et al. (6), 1 g ofPPM was dissolved in 50 ml of HCI (0.01 N),
and the solution was heated at 100°C for 30 min. After
cooling, the solution was neutralized with NaOH and lyoph-
ilized.
(iii) Mild alkaline hydrolysis. According to a method
adapted from that of Nakajima and Ballou (16), 585 mg of
PPM depleted of oligomannosides after mild acid hydrolysis
was dissolved in 50 ml of NaOH (0.1 N), incubated for 24 h
at 25°C under agitation, and then neutralized with acetic acid
(1 N) and lyophilized.
(iv) Gel filtration chromatography. After each hydrolysis,
the products were dissolved in water and settled on Bio-Gel
P4 (Biorad, Herdfordshire, England) columns (1.8 by 150
cm). The columns were eluted with distilled water at a flow
rate of 5 ml/h at room temperature. Fractions (2 ml) were
collected and analyzed by thin-layer chromatography.
(v) Thin-layer chromatography. The oligosaccharides were
separated on Silica Gel 60-precoated plates (Kieselgel 60,
Merck, Darmstadt, Germany) with n-butanol-acetic acid-
water (20/10/10, vol/vol/vol) as a solvent. The oligosaccha-
rides were stained with a solution of orcinol (2 g/liter) in 20%
sulfuric acid and heated at 105°C for 10 min. NGL were
settled on Silica Gel 60 F254-precoated plates (DC Alufolien
60 F254 Kieselgel, Merck) and separated with chloroform-
methanol-water (54/34/9.3, vol/vol/vol) as a solvent. Lipids
(free and included in NGL) were detected on the thin-layer
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chromatography plates by short-wave (254-nm) UV light.
The glycan moiety was stained by orcinol sulfuric reagent.
(vi) 'H NMR analysis. The solution of oligomannosides
was exchanged several times in D20 with intermediate
lyophilization. NMR spectral analysis of the compounds in
D20 (99.95%; Commissariat a l'Energie Atomique, Gif sur
Yvette, France) was carried out on a BRUCKER AM-400
WB Spectrometer operating in the Fourier transform mode
at a probe temperature of 300 K. Chemicals shifts are given
relative to sodium 2.2-dimethyl 2-silapentane 5-sulfonate
(indirectly to acetone in D20: 8 = 2.225 ppm). Resolution
enhancement of the 'H NMR spectrum was achieved by
Lorentzian-to-Gaussian transformation. Interpretation of
the 'H NMR spectrum was made according to Cohen and
Ballou (3).
Construction and analysis of NGLO. Construction and
analysis ofNGLO were carried out according to a previously
described method (6). Briefly, 100 mg of 4-hexadecylaniline
(Aldrich Chemical Co., Milwaukee, Wis.) was added to 500
[LI of a solution containing 35 mg of sodium cyanoborohy-
dride, 3.5 ml of methanol, and 400 RI of acetic acid. The
solution was heated at 80°C, and 1 mg of 0-linked oligoman-
nosides solubilized in 50 ,ul of water was added to 200 RI of
this solution and incubated at 80°C for 90 min. The solution
was cooled, mixed with chloroform and water added in equal
parts, and centrifuged. The aqueous phase was dried, dis-
solved in methanol (2 ml), and centrifuged. The supernatant
containing the NGLO was conserved.
ELISA procedure. The ELISA involved PPM and NGLO
coated onto 96-well polystyrene plates (Nunc Immuno Type
II).
The method was set up, as previously described for a
different pool of oligomannosides, by analyzing the reactiv-
ity of three patient sera with different IFA titers (5a). For
given concentrations of human antibodies and conjugates,
the elevation in optical density (OD) was related to the
quantity of PPM and NGLO until a maximum was reached.
We chose for both antigens the carbohydrate concentration
giving the best discrimination between sera with different
IFA titers. As before (5a), at these concentrations of antigen
and neoantigen, reactions with antibodies were found as to
be dose dependent and saturable.
Application of these analyses led to the definition of the
following methods as routine procedures. They were used
throughout the study.
For NGLO, each well received 50 ,ul of a 10-,ug/ml
solution of antigen in carbonate buffer (60 mM, pH 9.6).
Plates were incubated for 1 h at 37°C and overnight at 4°C
and then washed five times in TNT buffer (Tris, 50 mM;
NaCl, 150 mM; HCI [pH 7.5]; Tween 20, 0.05%). The last
wash was prolonged for 5 min. The plates were stored at
-20°C. All wells were saturated with a bovine serum albu-
min (Boehringer, Mannheim, Germany) solution diluted to
3% in TNT buffer lacking Tween. 50-pI volume of 1/1,000
serum diluted in TNT buffer was incubated in each well for
1 h at 37°C. After four washes in TNT, 50 pl of the
peroxidase-labeled antibody (goat anti-human immunoglob-
ulin IgG, IgM, and IgA [Biosoft, Paris, France, and Zymed
Laboratories, South San Francisco, Calif.]) diluted in TNT
(1/2,000) was incubated for 1 h at 37°C. After five washes in
TNT buffer, each well received 100 pI of the enzymatic
substrate via a solution of orthophenylenediamine at 1 g/liter
in TNT buffer with 0.5 pI of hydrogen peroxide (30%) per ml.
After 30 min of incubation at room temperature in the dark,
the reaction was stopped by adding 50 RI of 4 M H2SO4.




FIG. 1. Thin-layer chromatography of oligosaccharides released
by alkaline degradation (P elimination) on PPM depleted in oligosac-
charides linked through phosphodiester bonds by mild acid hydro-
lysis. Oligosaccharides were desorbed from a Bio-Gel P4 column
(1.8 by 150 cm). Seven spots, corresponding to oligosaccharides
containing one to seven mannose residues, can be seen. Three
controls were used: mannose (M), saccharose (S), and raffinose (R).
The arrow at the bottom indicates the point of application.
ELISA procedure using PPM antigen coated on ELISA
plates was similar except that (i) plates were coated with 100
,ul of a 1-,ug/ml solution of PPM, (ii) human sera (100 ,ul) were
used at a dilution of 1/8,000, and (iii) peroxidase-labeled
antibody (100 ,u) was used at a dilution of 1/1,000.
Statistical analyses. Correlations between results obtained
with all serological procedures on the 30 sera were studied
after a variable transformation for variance homogeneity
(27). The correlation coefficients were analyzed by the t test
(23).
RESULTS
Analysis of oligosaccharides released by mild alkaline deg-
radation. Thin-layer chromatography of oligosaccharides
released by elimination showed the presence of oligosac-
charides with one to seven mannose residues (Fig. 1). The
quantitatively major components were mannobiose and
mannotriose.
'H NMR analysis of mannobiose and mannotriose. The
NMR spectra of mannobiose and mannotriose (Fig. 2) were
assigned by the method of Cohen and Ballou (3). For the
mannobiose, the anomeric protons were observed at 8 =
5.043 ppm (terminal mannose B) and 5.378 ppm (reducing
mannose A, a anomer) (Fig. 2A). The coupling constants
were 1.8 Hz for B and Aa and 1.1 Hz for AP. For the
mannotriose, the anomeric protons were found to resonate
at 5.045 ppm (terminal mannose C), 5.297 ppm (internal
mannose B), 5.368 ppm (reducing mannose a), and 4.911
(reducing mannose P) (Fig. 2B). The coupling constant
observed for the C, B, and Aa signals was 1.8 Hz, which
confirms the a anomery. The results confirmed the structure
of the two 0-linked oligosaccharides as Man(al-2)Man and
Man(al-2)Man(al-2)Man.
Analysis of NGL. The pool of NGLO was analyzed by
thin-layer chromatography. Individual components were vi-
sualized either under UV light, according to their lipid
moieties (Fig. 3), or after orcinol staining according to their
carbohydrate moieties (data not shown). Seven bands were
identified. They were interpreted as resulting from the mi-
gration of Mannose-4hexadecylaniline to Mannohexaose-
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FIG. 2. 'H NMR spectra of the two quantitavely major oligomannosides released from C. albicans after ,3 elimination: mannobiose (A) and
mannotriose (B).
4hexadecylaniline, with two bands for the Mannobiose-
4hexadecylaniline.
Human humoral response against NGLO analyzed by
ELISA. (i) Analysis of individual responses. When sera from
individual patients were allowed to react against NGLO,
seroconversion, as revealed against C. albicans antigens by
the routine serological procedures (Table 1), corresponded
to an increase of the ELISA signal against NGLO (Fig. 4).
Strong differences were observed in the intensity of the
ELISA signal between individual patients either before or
after seroconversion. The OD for sera drawn before sero-
conversion were usually very low, ranging from 0.005 to
0.098, whereas the OD for sera taken after seroconversion
ranged from 0.086 to 0.499. The levels of both ELISA signals
were apparently irrelevant to the mycological data. How-
ever, an increase in OD against the neoantigen was system-
atically observed for any couple of sera, each patient being
his own control, confirming the antigenicity of NGLO.
(ii) Statistical analyses of serological tests. Variable trans-
formation for variance homogeneity in relation to IFA titers
led us to express the results of all serological tests except
Co-CIE by their logarithms. Linear regression analysis (Fig.
5) demonstrated the existence of a correlation between
ELISA-NGLO and IFA (Fig. 5A), Co-CIE (Fig. 5B), and
ELISA-PPM (Fig. 5C). The significance of all correlations
was greater than 0.001. The coefficient correlation squares
were respectively 0.665, 0.706, and 0.718, indicating that 66,
70, and 71% of variation in OD values against NGLO related


















FIG. 3. Thin-layer chromatography of NGL constructed by cou-
pling oligosaccharides released by 13 elimination to the 4-hexadec-
ylaniline. The NGL are revealed under UV light (254 nm) according
to their lipid moiety. The arrow at the bottom indicates the point of
application. Abbreviations: L, uncoupled lipid; coupled sugars
mannose (M), mannobiose (M2), mannotriose (M3), mannotetraose
(M4), mannopentose (M5), and mannohexaose (M6).
DISCUSSION
C. albicans cell wall PPM is a molecule which has been
extensively studied from chemical (12, 14, 24-26) and immu-
nological (4, 5, 7, 8, 18, 28) points of view. The final goal of
such studies is to define relationships between molecular
structure and immunoreactivity. However, because of the
lack of methodologies suitable for extensive screenings, no
data are available concerning the molecular basis of human








of the C. albicans oligomannoside repertoire are presently
restricted to antisera studied in highly specialized laborato-
ries able to produce and analyze large quantities of oligo-
mannosides (7). Faced with this problem, we have recently
developed a method of construction of NGL from oligoman-
nosides released by sequential depolymerization of the PPM.
Such neoantigens have been shown in experimental models
to exhibit immunogenicity and antigenicity (6), mimicking
the activity of C. albicans natural antigens. NGL coated on
ELISA plates have also been shown to react with mamma-
lian polyclonal or monoclonal immunoglobulins reacting
with the original PPM, according to dose-dependent and
saturable reactions (5a).
In the present work, this method has been applied to the
study of human antibodies able to react with the family of
oligomannosides linked to the PPM molecule by O-glycoside
linkages and released after ,3 elimination (16). Mild alkaline
degradation of C. albicans mannan, previously depleted in
oligomannosides attached through phosphodiester bonds,
led to the release of 0-linked oligomannosides containing
one to seven mannose residues. The structural determina-
tion of the major oligomannosides, mannobiose and manno-
triose, demonstrated the presence of (al-2) linkages. These
results are similar to those obtained by Podzorski et al. with
another C. albicans strain (18), except that those authors
described only six oligomannosides. Thin-layer chromatog-
raphy analysis of oligosaccharides after they were coupled to
4-hexadecylaniline allowed the efficiency of the binding to be
visualized and assessed. Each coupled oligomannoside ex-
cept the mannobiose appeared on the chromatogram as a
single band; the mannobiose gave two bands. The most
likely hypothesis to explain this observation would be re-
lated to the aglycone part of NGL, the aqueous solvent
triggering two different ionizations. This phenomenon hap-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 CC C
Patients
FIG. 4. Human serum reactivity against NGLO as analyzed by ELISA. Results are expressed as OD for each pair of sera drawn from the
15 selected patients. Sera drawn before seroconversion are represented by black bars, and sera drawn after seroconversion are represented
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FIG. 5. The graphs represent the relations between serological
results given by ELISA-NGLO and IFA (A) Co-CIE (B), and
ELISA-PPM (C). All the data except those for Co-CIE were used
after variable transformation. The curve's equations are noted on
the top of each graph; R2 is the coefficient correlation square
relating the two variables.
pened only for coupled mannobiose, the other oligommano-
sides being too heavy to be separated on thin-layer chro-
matograms according to their ionization patterns.
Despite the fact that an immunomodulatory role of C.
albicans 0-linked oligomannosides against human lympho-
cytic proliferation induced in vitro (18) has been demon-
strated, it was not known if these structures could react with
antibodies. From a physiopathological point of view, the
existence of antibodies reacting with these oligomannoside
species is an important consideration, since the antibodies
may interfere with the direct triggering of lymphoid cells
induced by these potential epitopes. The demonstration of
the existence of human antibodies able to react with
0-linked oligomannosides through conventional methods of
precipitation inhibition is in practice unrealizable because of
the amount of oligomannosides required for such experi-
ments (7, 17). Considering this lack of methodology adapted
to extensive screenings of C. albicans oligomannoside reac-
tivity with human and animal antibodies, we have recently
developed a method for constructing NGL from these resi-
dues. Following application of this method, oligomannosides
from various families (5a, 6) have been shown to bind to
conventional substrates for immunoanalysis through their
lipid carrier molecule and to be able to react with antibodies
according to dose-dependent and saturable reactions (5a).
Construction of NGL from C. albicans 0-linked oligoman-
nosides provided, for the first time, evidence of human
antibodies reacting with these residues. Evidence came both
from increased ELISA-NGLO signals following individual
seroconversions and from the close correlation observed
between reactivity of sera against NGLO and PPM. Despite
individual differences, whose diagnostic and prognostic sig-
nificance remains presently unclear, reactivity of patient
sera against neoantigens evaluated as a whole did not
significantly differ from that against the PPM from which the
neoantigens were derived. These results are compatible with
what is known about the structure of 0-linked oligomanno-
sides composed of Man a (1-2) and Man a (1-3) linkages
largely distributed through the N-linked part of the PPM
molecule (24); in the same way, the use of PPM depleted in
0-linked oligomannosides did not significantly affect PPM
reactivity against patient sera (unpublished data). It is also
consistent with the experimental evidence reported by Shi-
bata et al. (26) that, in contrast to mild acid hydrolysis, P
elimination did not affect the precipitating effect of antibod-
ies raised against different C. albicans serotypes. Therefore,
according to this lack of structural specificity of C. albicans
0-linked oligomannosides, it is impossible at the present
stage of this work to say if the antibody response demon-
strated here resulted from specific triggering of the human
immune system by these molecules or represented cross-
reactivity with antibodies generated against similar struc-
tures by other oligomannoside species of the mannan mole-
cule.
The acknowledged risk of our immunochemical approach,
which also exists with the precipitation inhibition reactions
in liquid phase used as a reference (7), is that neoantigens
could suffer chemical alterations during preparation proce-
dures so that their conformation would not mimic the natural
antigen. In this respect, the correlation observed between
the ELISA-PPM and ELISA-NGLO has been encouraging.
As an incidental finding, statistical analysis revealed no
interference between the results obtained and antigenemia,
as revealed by the Cand-tec test (9) in sera from 12 patients
(data not shown). Despite slight differences between individ-
ual antibody detection tests which appeared when the tests
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were compared two by two after an adapted variable trans-
formation, a good overall correlation was nevertheless ob-
served between them. This is not surprising, since all these
tests detect antibodies against C. albicans mannoproteins
according to their precipitation with a whole-cell extract
(20), their reactivity with the cell wall surface (22), or their
reactivity with the PPM extracted from the surface and
deeper layers of the cell wall (21). Construction of NGL
therefore provides a way for the determination of the mo-
lecular basis of the human antibody response against cell
wall mannan, which has so far been appreciated as a whole.
This analysis is currently being extended to other oligoman-
noside families to determine the prognosis and diagnostic
significance of their recognition by human immunoglobulin
isotypes.
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